Health & Science

CDC Study Reveals Millions of Americans Use Unapproved GLP-1s and Modify Doses

· GlobeWire Daily Science Desk · Source: arstechnica.com

2 min read

Key takeawaysA recent study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report indicates that millions of US adults used GLP-1 medications in 2025, with many altering their prescriptions or using unapproved compounded versions.
Millions of Americans are not taking their GLP-1 drugs as prescribed

Image: Ars Technica · Photo source · Resized and letterboxed to 16:9; no AI generation

A recent study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report indicates that millions of US adults used GLP-1 medications in 2025, with many altering their prescriptions or using unapproved compounded versions.

Researchers analyzed survey data collected between July and August 2025 from over 8,000 US adults. The findings estimate that approximately 9.8 percent of US adults—roughly 27 million people—used a glucagon-like peptide-1 receptor agonist in 2025 for conditions such as diabetes, weight loss, and related chronic health issues.

Key Findings on Medication Use

  • Modified Dosages: Nearly 44 percent of GLP-1 users reported using their medication differently than prescribed, including skipping doses, delaying refills, and taking smaller amounts.
  • Cost and Access Barriers: Over half of those modifying their usage cited cost or availability issues. Younger adults (ages 14–39) reported cost barriers at 58 percent, compared to 20 percent of adults aged 65 or older.
  • Compounded Medications: At least 23 percent of users reported using a compounded version of the drug, while 9 percent were unsure. Among compounded drug users, 62 percent modified their use, compared to 36 percent of brand-name drug users.

Safety and Regulatory Concerns

Compounded GLP-1 medications are designed to mimic FDA-approved drugs like Ozempic or Wegovy, but the compounded versions themselves are not reviewed or approved by the FDA for safety, quality, or effectiveness. Researchers highlighted that some websites selling compounded versions have used brand names or implied FDA approval, potentially misleading consumers.

The study authors emphasize the need for further research into real-world medication modifications to help guide clinical guidelines and ensure patient safety.

Practical Implications and Verification

  • Patients should consult healthcare professionals regarding prescription changes or concerns about medication costs.
  • Consumers can verify official health data and study details directly through the Centers for Disease Control and Prevention (CDC) and the Morbidity and Mortality Weekly Report.
Share this article
Read the original source: Millions of Americans are not taking their GLP-1 drugs as prescribed

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Science Desk — AI-assisted news based on attributed published sources.

More to read